Celtic Biotech
  • Home
  • Overview
  • Cancer Facts
  • Pipeline
  • The Team
  • Q & A
    • FAQ
    • Mechanism of Action
  • Clinical Trials
  • Contact
  • More
    • Home
    • Overview
    • Cancer Facts
    • Pipeline
    • The Team
    • Q & A
      • FAQ
      • Mechanism of Action
    • Clinical Trials
    • Contact
Celtic Biotech
  • Home
  • Overview
  • Cancer Facts
  • Pipeline
  • The Team
  • Q & A
    • FAQ
    • Mechanism of Action
  • Clinical Trials
  • Contact

Fighting Cancer Naturally

Fighting Cancer Naturally

Who We Are

Our Mission

Our Mission

Our Mission

 Celtic Biotech is developing novel candidate therapies for the treatment of solid cancers and pain in humans. Derived from specialised receptor binding proteins found in snake venom, these product candidates have the potential to increase survival,  improve quality-of-life and reduce treatment costs for cancer patients.

Our Focus

Our Mission

Our Mission

Celtic Biotech is focusing its research on solid tumours, including non-small-cell lung cancer (NSCLC), as its initial targets.  The Company's lead candidate, CB24 (Crotoxin), has been observed to be highly toxic to various tumour cell lines in pre-clinical and early clinical studies.

 

Contact Us

Sign up for news and alerts.

email: info@celticbiotech.com

Copyright © 2022 Celtic Biotech - All Rights Reserved.

This website uses cookies.

We would like to use cookies to analyse website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

DeclineAccept